Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lipocine Inc LPCN

Healthcare Biotechnology
Lipocine Inc. is a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery to develop differentiated products for Central Nervous System (CNS) disorders. Its clinical development candidates include: LPCN 1154, oral brexanolone, for treatment of postpartum depression, LPCN 2101 for epilepsy, LPCN 2203 for essential tremor... see more

Recent & Breaking News (NDAQ:LPCN)

LPCN LOSS NOTICE: TOP RANKED ROSEN LAW FIRM Reminds Lipocine Inc. Investors of Important January 14th Deadline in Securities Class Action - LPCN

GlobeNewswire December 14, 2019

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lipocine Inc. of Class Action Lawsuit and Upcoming Deadline - LPCN

ACCESSWIRE IA December 13, 2019

Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lipocine Inc. (LPCN), Armstrong Flooring, Inc. (AFI) & Wanda Sports Group Company Limited (WSG)

GlobeNewswire December 13, 2019

Lipocine Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Lipocine Inc. To Contact The Firm

Newsfile December 13, 2019

Lipocine Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Lipocine Inc. To Contact The Firm

Newsfile December 12, 2019

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lipocine Inc. of Class Action Lawsuit and Upcoming Deadline - LPCN

GlobeNewswire December 12, 2019

Lifshitz & Miller LLP Announces Investigation of Carolina Financial Corporation, Craft Brew Alliance, Inc., Foamix Pharmaceuticals Ltd., Grubhub Inc., Lipocine Inc., Pattern Energy Group, Inc., TD Ameritrade Holding Corporation, and William Lyon Homes

PR Newswire December 11, 2019

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lipocine, Armstrong Flooring, Wanda Sports Group, and Canopy Growth and Encourages Investors to Contact the Firm

PR Newswire December 11, 2019

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Lipocine Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA December 11, 2019

INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in Lipocine, Inc., Armstrong Flooring, Inc., and Grubhub, Inc. of Filing Deadlines

GlobeNewswire December 10, 2019

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lipocine Inc. of Class Action Lawsuit and Upcoming Deadline - LPCN

ACCESSWIRE IA December 9, 2019

Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lipocine Inc. (LPCN), Armstrong Flooring, Inc. (AFI) & Wanda Sports Group Company Limited (WSG)

ACCESSWIRE IA December 9, 2019

Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action Against Lipocine Inc. (LPCN), Armstrong Flooring, Inc. (AFI) & Wanda Sports Group Company Limited (WSG)

GlobeNewswire December 6, 2019

ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Lipocine Inc. Investors of Important January 14th Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - LPCN

GlobeNewswire December 5, 2019

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Plantronics, Lipocine, Armstrong Flooring, and Wanda Sports Group and Encourages Investors to Contact the Firm

GlobeNewswire December 4, 2019

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Lipocine Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA December 4, 2019

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lipocine Inc. of Class Action Lawsuit and Upcoming Deadline - LPCN

ACCESSWIRE IA December 4, 2019

INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in Lipocine, Inc., Armstrong Flooring, Inc., and Grubhub, Inc. of Filing Deadlines

GlobeNewswire December 4, 2019

SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lipocine Inc. of Class Action Lawsuit and Upcoming Deadline - LPCN

GlobeNewswire December 2, 2019

Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action Against Lipocine Inc. (LPCN), Armstrong Flooring, Inc. (AFI) & Wanda Sports Group Company Limited (WSG)

ACCESSWIRE IA December 2, 2019